Calcium signalling in astrocytes couples changes in neural activity to alterations in cerebral blood flow by eliciting vasoconstriction or vasodilation of arterioles. However, the mechanism for how these opposite astrocyte influences provide appropriate changes in vessel tone within an environment that has dynamic metabolic requirements remains unclear. Here we show that the ability of astrocytes to induce vasodilations over vasoconstrictions relies on the metabolic state of the rat brain tissue. When oxygen availability is lowered and astrocyte calcium concentration is elevated, astrocyte glycolysis and lactate release are maximized. External lactate attenuates transporter-mediated uptake from the extracellular space of prostaglandin E 2 , leading to accumulation and subsequent vasodilation. In conditions of low oxygen concentration extracellular adenosine also increases, which blocks astrocyte-mediated constriction, facilitating dilation. These data reveal the role of metabolic substrates in regulating brain blood flow and provide a mechanism for differential astrocyte control over cerebrovascular diameter during different states of brain activation.
In the brain, regional changes in neural activity trigger localized alterations in cerebral blood flow 1 through astrocyte activation 2, 3 . A rise in intracellular free calcium concentration ([Ca 21 ] i ) within astrocyte endfeet, which collectively circumscribe all cerebral vessels 4 , initiates vasoconstriction [5] [6] [7] or vasodilation 2, 6, [8] [9] [10] . Cerebral blood flow couples to the lactate/pyruvate ratio and the related nicotinamide adenine dinucleotide (NADH)/NAD 1 ratio [11] [12] [13] , but links between these metabolic substrates and the mechanisms of cerebral blood flow regulation remain unresolved. We tested the hypothesis that the metabolic state of the tissue, altered by oxygen (O 2 ) availability, dictates the type of astrocyte influence on arteriole diameter. At the onset of neural activity dendrites rapidly consume O 2 (ref. 14) , leading to a reduction in oxygen pressure (p O2 ) [15] [16] [17] and oxyhaemoglobin 18, 19 , which occurs before the increase in cerebral blood flow. Brain metabolism then shifts, whereby glycolysis is enhanced 20, 21 in astrocytes 14 and lactate is released 22, 23 . Lactate is vasoactive 12, 24 and dynamically alters microvasculature diameter in an O 2 -dependent manner 25 . Vasodilation occurs in the brain region experiencing the O 2 drop, whereas vasoconstriction ensues in the inactive surrounding area 26 . Delineating the cellular processes responsible for O 2 -metabolic effects on cerebral blood flow may be crucial for treating stroke and vascular dementia, as well as aiding in our understanding of neurovascular coupling for the scientific and diagnostic uses of functional magnetic resonance imaging. p O2 converts polarity of vessel response We tested whether p O2 consistently determined if vasoconstrictions or vasodilations were evoked by synaptic activation or by astrocyte Ca 21 transients in rat brain slices. In response to periodic 10-20-Hz stimulation of the hippocampal CA3-CA1 pathway in conditions of high O 2 concentration (95%) arterioles constricted (81.4 6 3.8% (100% 5 control diameter), n 5 6, P , 0.007), whereas the same vessel in low O 2 concentration (20%) dilated (107.6 6 0.7%, n 5 6, P , 0.005, P , 0.0003 to each other, Fig. 1a -c) in response to the same stimulation. To determine the impact of p O2 on astrocyte control of arteriole diameter we applied the metabotropic glutamate receptor (mGluR) agonist (6)-1-aminocyclopentane-trans-1,3dicarboxylic acid (tACPD) (100 mM), which potently increased astrocyte [Ca 21 ] i 2,5,8 (240.0 6 19.1%, n 5 14, P , 0.001, Fig. 2a ) and caused arteriole dilation in conditions of low O 2 concentration (107.0 6 0.8%, n 5 23, P , 0.001, Fig. 2a , f) but constriction in conditions of high O 2 concentration 5 (85.4 6 4.0%, n 5 10, P , 0.006, Fig. 2f ). Next we used two-photon photolysis of the Ca 21 cage dimethoxy-nitrophenyl-EGTA-4 (DMNPE-4) 27 to liberate directly astrocyte Ca 21 and examine the vessel response. Uncaging DMNPE-4 triggered a Ca 21 wave that spread to multiple astrocyte endfeet ( Fig. 2b, c) . In contrast to previous results in conditions of high O 2 concentration where astrocyte endfeet Ca 21 caused constriction 5 , in conditions of low O 2 endfeet Ca 21 (232.2 6 8.5%, n 5 17, P , 0.001) caused dilation (107.4 6 1.0%, n 5 17, P , 0.003, Fig. 2b , c, f). These data indicate that p O2 dictates the direction of arteriole diameter change when astrocytes are activated ( Supplementary Fig. 2 for p O2 measurements).
Vasodilation requires COX and PGE 2
Astrocyte Ca 21 activates cytosolic phospholipase A 2 , triggering formation of arachidonic acid that is either converted to 20-hydroxyeicosatetraenoic acid (20-HETE) in smooth muscle cells causing vasoconstriction 5 or to the vasodilator prostaglandin E 2 (PGE 2 ) in astrocytes via cyclooxygenase (COX) 2, 9 . We verified COX1 and COX2 expression in astrocytes and their endfeet ( Supplementary  Fig. 3 ). The COX inhibitor indomethacin (100 mM) blocked vasodilations caused by tACPD (98.4 6 0.8%, n 5 9, P , 0.0001 to tACPD alone, Fig. 2f ) and by caged Ca 21 photolysis (101.0 6 0.5%, n 5 6, P , 0.002 to uncaging alone, Fig. 2d , f) in conditions of low O 2 concentration. Application of the COX product PGE 2 (1 mM) elicited vasodilation (109.4 6 2.7%, n 5 4, P , 0.05, Fig. 2e ), confirming COX activation and that the generation of PGE 2 is an important signalling molecule in astrocyte-mediated vasodilations in conditions of low O 2 concentration 2,9 .
We investigated how changing p O2 could modify the type of astrocyte influence on arterioles. Lowering p O2 may elevate anaerobic metabolism, increasing external lactate. Notably, the action of PGE 2 is terminated when prostaglandin transporters (PGTs) take up PGE 2 by an exchange of intracellular lactate 28 . Owing to the influence of a lactate concentration gradient on PGT efficacy, we tested the hypothesis that higher levels of extracellular lactate reduce PGT uptake of PGE 2 , thereby increasing the external PGE 2 concentration resulting in vasodilation. Immunohistochemistry revealed that PGT was expressed in astrocyte endfeet ( Fig. 3a ) and neurons ( Fig. 3b ), indicating that both cell types take up PGE 2 . Consistent with a positive correlation between external lactate and external PGE 2 , low O 2 concentration enhanced both lactate release (low O 2 , 114.2 6 9.1 mM, n 5 6; high O 2 , 41.9 6 5.6 mM, n 5 6, P , 0.001, Fig. 3c ) and extracellular PGE 2 levels when PGE 2 production was triggered by tACPD (low O 2 , 136.1 6 10.2 pg ml 21 , n 5 6; high O 2 , 91.9 6 12.6 pg ml 21 , n 5 4, P , 0.001, Fig. 3d ). Addition of lactate (1 mM) enhanced the PGE 2 level (control, 40.5 6 3.3 pg ml 21 ; with lactate, 58.0 6 3.1 pg ml 21 , n 5 5, P , 0.01) and increased arteriole diameter (107.5 6 1.0%, n 5 15, P , 0.0001, Fig. 3e -g). Lactate-induced dilations were blocked by indomethacin (100.4 6 0.4%, n 5 11, P , 0.0001 to lactate alone, Fig. 3g ), indicating that they were mediated by PGE 2 via the COX pathway. These data indicate that in low O 2 concentration higher levels of extracellular lactate raise external levels of PGE 2 .
Vasodilation requires lactate
We examined the role of astrocyte glycolysis in lactate production 23, 29 by imaging the intrinsic fluorescence of the metabolic electron carrier NADH 30 . Two-photon excitation of NADH provides a measure of both oxidative metabolism (punctate mitochondrial fluorescence) and glycolytic metabolism (diffuse cytosolic fluorescence) 14 . We observed that astrocytes, stained with SR-101 (ref. 31) , showed diffuse NADH fluorescence in the soma and endfeet ( Fig. 3h , i). Stimulating glycolysis with low O 2 increased the astrocyte NADH signal (124.6 6 1.4%, n 5 5, P , 0.003, Fig. 3i , j) and inhibiting glycolysis with iodoacetate (200 mM) reduced basal NADH levels (87.8 6 2.0%, n 5 5, P , 0.004, Fig. 3k ). Inhibiting lactate dehydrogenase (LDH, which converts pyruvate and NADH to lactate and NAD 1 ; Supplementary Fig. 1 ) with oxamate (2.5 mM) increased NADH (119.3 6 2.0%, n 5 6, P , 0.004, Fig. 3l ). These data indicate that astrocyte glycolysis can be augmented by reducing p O2.
Recent two-photon NADH imaging demonstrated an increase in astrocyte glycolysis caused by neuronal activity 14 . We proposed that mGluR activation enhances astrocyte glycolysis in conditions of low O 2 , promoting increases in extracellular lactate and vasodilation. tACPD triggered an increase in astrocyte NADH (128.7 6 4.1%, n 5 7, P , 0.0005, Fig. 4a -e) coincident with lumen widening (108.5 6 0.7%, n 5 7, P , 0.01, Fig. 4b, c ). tACPD enhanced extracellular lactate, which was greatest in low O 2 (low O 2 , 186.7 6 11.2 mM, n 5 6; high O 2 , 98.6 6 10.2 mM, n 5 7, P , 0.001, Fig. 4f ). For additional NADH measurements see Supplementary Figs 4 and 5. We used two pharmacological treatments to limit lactate release. Using iodoacetate to block the source of lactate, tACPD instead decreased astrocyte NADH (81 6 0.4%, n 5 5, P , 0.0001 to tACPD alone, Fig. 4g ) and failed to dilate vessels (97.8 6 0.2%, n 5 5, P , 0.0001 to tACPD alone, Fig. 4i ). The NADH signal decrease was probably due to tACPD-induced astrocyte swelling. Using oxamate to curtail lactate formation, tACPD still increased astrocyte NADH (112.8 6 3.1%, n 5 6, P , 0.02, Fig. 4h ; see Supplementary Fig. 1 ), yet vasodilations no longer occurred (99.0 6 0.1%, n 5 6, P , 0.0001 to tACPD alone, Fig. 4i ). The lack of dilation was associated with reduced extracellular lactate (tACPD, 180.2 6 11.9 mM, n 5 6; plus iodoacetate, 88.2 6 8.8 mM, n 5 6, P , 0.001; plus oxamate, 89.1 6 6.6 mM, n 5 6, P , 0.001, Fig. 4j ) and PGE 2 (tACPD, 154.0 6 10.1 pg ml 21 , n 5 4; plus iodoacetate, 115.4 6 10.6 pg ml 21 , n 5 6, P , 0.001; plus oxamate, 94.6 6 7.6 pg ml 21 , n 5 6, P , 0.01, Fig. 4k ). Because PGE 2 is the final effector molecule on smooth muscle cells, we rescued vasodilation with PGE 2 in iodoacetate (109.0 6 1.3%, P , 0.002, n 5 5, Fig. 4i ) or in oxamate (109.2 6 2.2%, P , 0.02, n 5 5, Fig. 4i and Supplementary Fig. 6 ). These data demonstrate that inhibition of glycolysis or LDH limits extracellular lactate and PGE 2 accumulation in response to tACPD in low O 2 conditions, preventing astrocytemediated vasodilations.
Adenosine blocks vasoconstriction
Our data do not yet explain why vasoconstrictions are absent in low O 2 . A low-O 2 environment causes an elevation in extracellular adenosine 32, 33 , and adenosine A2A receptors reduce smooth muscle cell Ca 21 channel activity 34 , which normally acts to induce smooth muscle cell contraction. We hypothesized that A2A receptor activation prevents astrocyte-mediated vasoconstriction. Adenosine also suppresses synaptic glutamate release through the A1 receptor 33 ; thus, we confirmed an elevated adenosine concentration in low O 2 when the A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 100 nM) increased the slope of the extracellular field potential (low O 2 , 277.7 6 63.6%, n 5 9; high O 2 , 99.1 6 7.1%, P , 0.05, n 5 5, Fig. 5a ) and decreased the paired-pulse ratio (low O 2 , 1.79 6 0.04; plus DPCPX, 1.42 6 0.05, P , 0.0001, n 5 9; high O 2 , 1.47 6 0.01; plus DPCPX, 1.49 6 0.03, P . 0.5, n 5 5, Fig. 5a ) only in low O 2 . In the presence of adenosine (100 mM), uncaging astrocyte Ca 21 in high O 2 concentration resulted in no vasoconstriction (99.6 6 0.9%, P . 0.6, n 5 4, Supplementary Fig. 7 ). After an initial uncaging event that caused constriction (87.1 6 1.3%, P , 0.002, Fig. 5b ), the A2A receptor agonist CGS21680 (1 mM) blocked subsequent constriction (99.3 6 0.5%, P , 0.0004 to constriction, n 5 7, Fig. 5b ) despite similar astrocyte Ca 21 signals (F/F 0 5 179.9 6 10.9%; plus CGS21680 F/F 0 5 173.8 6 10.3%, n 5 7, P . 0.7). A2A receptor activation did not affect PGE 2 in response to tACPD (217.0 6 20.4%, n 5 5; plus CGS21680, 186.6 6 12.1%, n 5 6, P . 0.2), allowing vasodilations to proceed in low O 2 . These data demonstrate that increasing extracellular adenosine levels, which occurs in low O 2 , prevents astrocyte-mediated vasoconstriction, thereby facilitating the switch to vasodilation. Fig. 5c ) and dilated arterioles (107.0 6 0.8%, P , 0.001, n 5 7, Fig. 5d ), indicating tonic PGE 2 uptake. Adding tACPD further enhanced the PGE 2 level (T34 plus tACPD, 1,048.9 6 173.6%, P , 0.02 compared to T34, n 5 3, Fig. 5c ) and caused further dilation (T34 plus tACPD, 109.1 6 1.3%, P , 0.0004 from T34 baseline, n 5 7, Fig. 5d ), indicating that PGE 2 release occurs by diffusion and not by the transporter 36 . However, adding lactate did not further augment PGE 2 (T34 plus tACPD plus lactate, 1,134.2 6 138.7%, P . 0.4 compared to T34 plus tACPD, n 5 4, Fig. 5c ) in contrast to the additive effects of lactate and tACPD without T34 (lactate, 124.0 6 11.9%, P , 0.02, n 5 3; tACPD, 145.6 6 11.6%, P , 0.001, n 5 6; lactate plus tACPD, 207.0 6 24.3%, n 5 3, P , 0.005 to tACPD or lactate alone, Fig. 5c ). Dilation caused by T34 was not increased further by lactate (T34 plus lactate, 99.4 6 1.4%, P . 0.1 from T34 baseline, n 5 9, Fig. 5d ). These data indicate that T34 occludes the lactate effects of raising PGE 2 and causing vasodilation. This demonstrates that PGT efficacy controls the PGE 2 level and thus vascular tone.
PGE 2 and adenosine convert constrictions
We reasoned that adding lactate (100 mM to 1 mM) and adenosine (100 mM) in conditions of high O 2 would enable astrocyte-mediated constrictions to convert to dilations by attenuating PGE 2 uptake and blocking vasoconstriction, respectively. Under this condition, Ca 21 uncaging now resulted in dilation (107.5 6 1.4%, P , 0.004 to adenosine alone, n 5 9, Fig. 5d, e ), despite equivalent Ca 21 signals in astrocyte endfeet compared with adenosine alone (adenosine, F/F 0 5 160.4 6 6.1%, n 5 4; plus lactate, F/F 0 5 159.6 6 5.1%, P . 0.8, n 5 9, Supplementary Fig. 7 ). We hypothesized that PGT blockade by T34 in high O 2 would have a similar result by reducing PGE 2 uptake, thereby raising extracellular PGE 2 . In the same vessel, an initial uncaging event caused constriction (87.4 6 1.8%, P , 0.009, Fig. 5d , f) but a second uncaging event in the presence of T34 and adenosine caused dilation (108.7 6 1.4%, n 5 5, P , 0.02, P , 0.0001 to constriction, Fig. 5d, f) . These data indicate that astrocytes induce vasodilation over vasoconstriction when constrictions are prevented by adenosine and PGE 2 uptake is reduced by elevated lactate.
Here we show that by lowering p O2 , astrocyte-induced responses convert to vasodilations from vasoconstrictions. Astrocyte Ca 21 transients from mGluR activation trigger the synthesis of diffusible arachidonic acid and PGE 2 . In high O 2 , extracellular PGE 2 is rapidly cleared by PGTs as a result of low extracellular lactate levels. This keeps extracellular PGE 2 levels low and allows astrocyte-derived arachidonic acid to constrict arterioles 5 . In low O 2 , astrocyte glycolysis is enhanced and extracellular lactate increases. High external lactate hinders PGE 2 clearance and increases extracellular PGE 2 , which dilates arterioles. In addition, increased adenosine release in low O 2 inhibits astrocyte-mediated vasoconstrictions at the level of smooth muscle cells, blocking the effect of arachidonic acid ( Supplementary Fig. 1 ). Flow through blood vessels is proportional to vessel radius to the fourth power; therefore, a ,9% change in arteriole diameter reported here equates to a ,45% increase in cerebral blood flow. This change is consistent with astrocytemediated vasodilations observed in vivo 8 and can account for cerebral blood flow changes measured by positron emission tomography 37 and with two-photon microscopy 38, 39 during physiological activation. Previous studies on the bidirectional control of vessel diameter implicated different populations of GABA neurons 40 , nitric oxide levels 6 and pericytes 41 . Our data indicate that the separate yet competing molecular pathways regulating cerebral blood flow from astrocytes would reach an equilibrium, which shifts depending on the degree of metabolic activity. Under more quiescent periods when O 2 is not being rapidly consumed, astrocyte Ca 21 signals induce constrictor tone, keeping cerebral blood flow at an appropriate lower level. During more active periods, the drop in p O2 from oxygen consumption and the rise in extracellular lactate and adenosine promote astrocyte-mediated dilation. Manipulating this balance may be a therapeutic avenue for treating the inappropriate declines in cerebral blood flow that occur in some dementias and after stroke.
METHODS SUMMARY
Hippocampal-neocortical slices were prepared from juvenile (postnatal age 16-21 days), male, Sprague-Dawley rats. Treatment of animals was approved by the University of British Columbia Animal Care and Use Committee. Artificial cerebrospinal fluid (ACSF) bubbled with 95% O 2 , 5% CO 2 , was defined as high O 2 and 20% O 2 , 5% CO 2 , balanced N 2 , was defined as low O 2 . Astrocytes were loaded with the Ca 21 cage DMNPE-4/AM (10 mM) and/or the Ca 21 indicator rhod-2/AM (10 mM) as previously described 5 . A two-photon laser-scanning microscope (Zeiss LSM510-Axioskop-2 fitted with a 40X-W/0.80 numerical aperture objective lens) coupled to a Chameleon ultra-tunable ultra-fast laser (,100-fs pulses 76 MHz, Coherent) provided excitation of rhod-2, intrinsic NADH and was used for uncaging Ca 21 . Arterioles were imaged by acquiring the transmitted laser light and using IR-DIC optics. Quantification of lumen diameter, NADH and Ca 21 changes were performed with Zeiss LSM (version 3.2) software and ImageJ. The assay used for measuring PGE 2 release was Specific Parameter PGE 2 ELISA kits (R&D systems). Extracellular lactate levels were measured using a lactate assay kit (Biomedical Research Service Centre). Experimental values are the mean 6 s.e.m., expressed as a percentage of 100% control. 
